Cargando…
Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment
Tumors arising at the lacrimal sac are extremely rare, as a limited number of cases have been reported worldwide. They are commonly primary and the majority of them are malignant and epithelial in origin. Adenocarcinomas account for a small percentage of these tumors. Treatment of local disease main...
Autores principales: | Vagia, Elena, Economopoulou, Panagiota, Oikonomopoulos, Nikolaos, Athanasiadis, Ilias, Dimitriadis, George, Psyrri, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313611/ https://www.ncbi.nlm.nih.gov/pubmed/25699235 http://dx.doi.org/10.3389/fonc.2015.00010 |
Ejemplares similares
-
Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020) -
Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial
por: Ohlmann, Carsten-Henning, et al.
Publicado: (2017) -
Lacrimal sac mucocele()
por: do Nascimento, Silvia Bona, et al.
Publicado: (2014) -
Occult oncocytoma of the lacrimal sac
por: Mulay, Kaustubh, et al.
Publicado: (2014) -
A Surprise in the Lacrimal Sac
por: Yuksel, Nilay, et al.
Publicado: (2016)